Does HYDROXYCHLOROQUINE DIPHOSPHATE Cause Therapeutic product effect decreased? 345 Reports in FDA Database

Q: Does HYDROXYCHLOROQUINE DIPHOSPHATE cause Therapeutic product effect decreased?

345 reports of Therapeutic product effect decreased have been filed with the FDA for HYDROXYCHLOROQUINE DIPHOSPHATE, representing 18.5% of all HYDROXYCHLOROQUINE DIPHOSPHATE adverse event reports.

Q: How dangerous is Therapeutic product effect decreased from HYDROXYCHLOROQUINE DIPHOSPHATE?

Of 345 reports, 44 (12.8%) resulted in death and 119 required hospitalization.

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 345 reports of Therapeutic product effect decreased have been filed in association with HYDROXYCHLOROQUINE DIPHOSPHATE. This represents 18.5% of all adverse event reports for HYDROXYCHLOROQUINE DIPHOSPHATE.

345

Reports of Therapeutic product effect decreased with HYDROXYCHLOROQUINE DIPHOSPHATE

18.5%

of all HYDROXYCHLOROQUINE DIPHOSPHATE reports

Deaths

119

Hospitalizations

How Dangerous Is Therapeutic product effect decreased From HYDROXYCHLOROQUINE DIPHOSPHATE?

Of the 345 reports, 44 (12.8%) resulted in death, 119 (34.5%) required hospitalization, and 71 (20.6%) were considered life-threatening.

Is Therapeutic product effect decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYDROXYCHLOROQUINE DIPHOSPHATE. However, 345 reports have been filed with the FAERS database.

What Other Side Effects Does HYDROXYCHLOROQUINE DIPHOSPHATE Cause?

Drug ineffective (1,220) Rheumatoid arthritis (914) Pain (633) Drug intolerance (607) Joint swelling (559) Fatigue (523) Arthralgia (487) Contraindicated product administered (463) Abdominal discomfort (456) Off label use (441)

What Other Drugs Cause Therapeutic product effect decreased?

ADALIMUMAB (11,058) METHOTREXATE (8,952) ETANERCEPT (8,819) ABATACEPT (7,256) TOCILIZUMAB (7,208) LEFLUNOMIDE (7,025) HYDROXYCHLOROQUINE (6,450) INFLIXIMAB (6,401) RITUXIMAB (6,281) GOLIMUMAB (5,478)

Which HYDROXYCHLOROQUINE DIPHOSPHATE Alternatives Have Lower Therapeutic product effect decreased Risk?

HYDROXYCHLOROQUINE DIPHOSPHATE vs HYDROXYETHYL STARCH 130/0.4 HYDROXYCHLOROQUINE DIPHOSPHATE vs HYDROXYPROGESTERONE HYDROXYCHLOROQUINE DIPHOSPHATE vs HYDROXYPROGESTERONE CAPROATE HYDROXYCHLOROQUINE DIPHOSPHATE vs HYDROXYPROPYL CELLULOSE HYDROXYCHLOROQUINE DIPHOSPHATE vs HYDROXYUREA

HYDROXYCHLOROQUINE DIPHOSPHATE Full Profile All Therapeutic product effect decreased Reports All Drugs Causing Therapeutic product effect decreased HYDROXYCHLOROQUINE DIPHOSPHATE Demographics